Efficacy and Safety of Trastuzumab Combined with Pertuzumab for Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer: A Meta-Analysis Study of Randomized Control Trials

Figure 5

Sensitivity analysis of gastrointestinal adverse reactions. (a) Sensitivity analysis of diarrhea. (b) Sensitivity analysis of nausea. (c) Sensitivity analysis of vomiting. (d) Sensitivity analysis of constipation.

(a)

(b)

(c)

(d)